discuss in detail schistosomiasis, cause organism, types of s schistosomiasis ,signs and symptoms prevalence, prevention and treatment
Struggling with where to start this assignment? Follow this guide to tackle your assignment easily!
1. What is Schistosomiasis?
Schistosomiasis, also known as bilharzia, is a chronic parasitic disease caused by blood flukes (trematode worms) of the genus Schistosoma. It is considered one of the neglected tropical diseases (NTDs) and primarily affects populations in poor and rural areas without adequate access to safe water and sanitation.
2. Causative Organisms
The disease is caused by several species of Schistosoma, with the main pathogenic types affecting humans being:
-
Schistosoma haematobium – causes urinary schistosomiasis
-
Schistosoma mansoni – causes intestinal schistosomiasis
-
Schistosoma japonicum – also causes intestinal schistosomiasis
-
Less common species:
-
S. mekongi
-
S. intercalatum
-
3. Types of Schistosomiasis
Based on the species and the site of infection, schistosomiasis is categorized into:
a. Urinary Schistosomiasis
-
Caused by S. haematobium
-
Affects the urinary tract, primarily the bladder
b. Intestinal Schistosomiasis
-
Caused by S. mansoni, S. japonicum, S. mekongi, and S. intercalatum
-
Affects the intestines and liver
c. Cerebral and Spinal Schistosomiasis
-
Occurs when eggs migrate to the brain or spinal cord
-
Rare but severe complications such as seizures or paralysis
4. Signs and Symptoms
Early Stage (within days of infection)
-
Often asymptomatic
-
May develop “swimmer’s itch” – a skin rash at the site of parasite entry
Acute Phase (Katayama fever, 2–8 weeks post-infection)
-
Fever
-
Chills
-
Cough
-
Muscle aches
-
Enlarged lymph nodes, liver, and spleen
-
Eosinophilia (high eosinophil count in blood)
Chronic Phase
-
Urinary Schistosomiasis:
-
Hematuria (blood in urine)
-
Painful urination
-
Bladder fibrosis
-
Increased risk of bladder cancer
-
-
Intestinal Schistosomiasis:
-
Abdominal pain
-
Diarrhea (often bloody)
-
Liver and spleen enlargement
-
Portal hypertension, ascites
-
5. Prevalence and Distribution
-
According to the World Health Organization (WHO), over 250 million people require preventive treatment annually.
-
Endemic in Africa, the Middle East, South America, and Southeast Asia.
-
Sub-Saharan Africa bears the highest burden, especially in school-aged children.
6. Transmission and Lifecycle
-
Schistosomes live in freshwater snails during part of their lifecycle.
-
Human infection occurs through skin contact with contaminated water.
-
Larvae (cercariae) penetrate the skin, enter the bloodstream, and mature into adult worms in blood vessels.
-
Adults lay eggs, which cause immune reactions and tissue damage.
7. Prevention
a. Public Health Measures
-
Improving access to safe water and sanitation
-
Snail control using molluscicides
-
Health education to reduce freshwater exposure
b. Behavioral Changes
-
Avoid swimming or wading in freshwater in endemic areas
-
Use protective footwear and clothing if contact is unavoidable
c. Mass Drug Administration (MDA)
-
WHO recommends annual or biannual administration of praziquantel to at-risk populations, especially school-aged children
8. Diagnosis
-
Microscopic examination of stool or urine to detect eggs
-
Serological tests for antibodies or antigens
-
PCR testing in advanced labs
-
Imaging (e.g., ultrasound) for assessing organ damage
9. Treatment
Drug of Choice: Praziquantel
-
Highly effective against all major Schistosoma species
-
Given as a single oral dose, often based on body weight (40–60 mg/kg)
-
Safe and well-tolerated, including in children
Supportive Treatment
-
Managing complications such as liver fibrosis or urinary obstruction
-
Corticosteroids may be used in severe immune reactions (e.g., Katayama syndrome)
10. Outlook and Global Impact
Schistosomiasis causes significant morbidity, including anemia, growth retardation in children, and organ damage. While not often fatal, it severely reduces quality of life. Global efforts to eliminate it as a public health problem are ongoing, with goals of expanded access to preventive chemotherapy and sanitation improvements.
References
-
World Health Organization. (2023). Schistosomiasis. https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
-
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014). Human schistosomiasis. The Lancet, 383(9936), 2253–2264.
-
CDC. (2023). Parasites – Schistosomiasis. https://www.cdc.gov/parasites/schistosomiasis/
Place this order or similar order and get an amazing discount. USE Discount code “GET20” for 20% discount